Soligenix Inc
NASDAQ:SNGX

Watchlist Manager
Soligenix Inc Logo
Soligenix Inc
NASDAQ:SNGX
Watchlist
Price: 1.23 USD Market Closed
Market Cap: 12.4m USD

Relative Value

There is not enough data to reliably calculate the relative value of SNGX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SNGX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
36
Median 3Y
32.8
Median 5Y
133.3
Industry
7.9
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-10.1
Industry
23.7
Forward
-0.5
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-8.9
Industry
22
vs History
vs Industry
Median 3Y
-1
Median 5Y
-6
Industry
23.8
vs History
65
vs Industry
62
Median 3Y
2
Median 5Y
11.9
Industry
3.3
vs History
vs Industry
86
Median 3Y
-3.1
Median 5Y
86.3
Industry
8.3
vs History
vs Industry
81
Median 3Y
-46.2
Median 5Y
279
Industry
10.1
vs History
vs Industry
22
Median 3Y
-0.1
Median 5Y
-8.3
Industry
6.4
vs History
vs Industry
20
Median 3Y
-0.1
Median 5Y
-8.3
Industry
7
Forward
-0.1
vs History
vs Industry
24
Median 3Y
-0.2
Median 5Y
-8
Industry
8.3
vs History
vs Industry
20
Median 3Y
-0.2
Median 5Y
-8
Industry
6.5
vs History
vs Industry
13
Median 3Y
-4.1
Median 5Y
-55.4
Industry
5.7

Multiples Across Competitors

SNGX Competitors Multiples
Soligenix Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Soligenix Inc
NASDAQ:SNGX
12.1m USD 0 -1.1 -0.1 -0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 837 682.7 -160 825.5 -195 293.4 -193 064.9
US
Abbvie Inc
NYSE:ABBV
393.8B USD 6.6 167.7 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
174.5B USD 4.9 24.9 18 18
US
Gilead Sciences Inc
NASDAQ:GILD
150.9B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.6B USD 9.7 30.9 22.7 23.7
US
Epizyme Inc
F:EPE
94.1B EUR 2 082 -531.3 -578.5 -563.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.8B USD 5.5 17.2 16.4 18.6
AU
CSL Ltd
ASX:CSL
84.9B AUD 3.6 18.7 12.6 15.8
NL
argenx SE
XBRU:ARGX
44.5B EUR 14.5 34.1 58.7 60.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.2B USD 16.3 1 198.1 157.3 190.8
P/S Multiple
Revenue Growth P/S to Growth
US
Soligenix Inc
NASDAQ:SNGX
Average P/S: 3 383 983.1
Not Available
62%
N/A
FR
Pharnext SCA
OTC:PNEXF
33 837 682.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.7
10%
1
US
E
Epizyme Inc
F:EPE
2 082
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.5
6%
0.9
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
NL
argenx SE
XBRU:ARGX
14.5
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.3
46%
0.4
P/E Multiple
Earnings Growth PEG
US
Soligenix Inc
NASDAQ:SNGX
Average P/E: 188.8
Negative Multiple: -1.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 825.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
167.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.9
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
9%
1.9
AU
CSL Ltd
ASX:CSL
18.7
11%
1.7
NL
argenx SE
XBRU:ARGX
34.1
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 198.1
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Soligenix Inc
NASDAQ:SNGX
Average EV/EBITDA: 39.3
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 293.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.7
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.4
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
NL
argenx SE
XBRU:ARGX
58.7
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
157.3
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Soligenix Inc
NASDAQ:SNGX
Average EV/EBIT: 45.3
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 064.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.7
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.6
13%
1.4
AU
CSL Ltd
ASX:CSL
15.8
11%
1.4
NL
argenx SE
XBRU:ARGX
60.4
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
190.8
N/A N/A